Lifecore Biomedical (LFCR) Earnings Date, Estimates & Call Transcripts

Lifecore Biomedical logo
$6.40 -0.01 (-0.08%)
As of 12:49 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Lifecore Biomedical Earnings Summary

Lifecore Biomedical announced Q1 2027 earnings on November 4, 2026, reporting an EPS of -$1.08, which missed the consensus estimate of -$0.30 by $0.78. Quarterly revenue was reported to be $25.32 million, below analysts' expectations of $25.57 million. With a trailing EPS of -$1.86, Lifecore Biomedical's earnings are expected to grow next year, from ($1.83) to ($1.08) per share.

Latest Q1
Earnings Date
Nov. 4Estimated
Consensus EPS
(Nov. 4)
-$0.30
Actual EPS
(Nov. 4)
-$1.08 Missed By -$0.78
Actual Revenue
(Nov. 4)
$25.32M

Q1 2027 Earnings Resources

Get Lifecore Biomedical Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Lifecore Biomedical and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

LFCR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LFCR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Lifecore Biomedical Analyst EPS Estimates & Company Guidance

Low, high and average are individual analyst estimates we track. Guidance columns are the company's own outlook, and the revenue estimate was recorded when that guidance was issued.

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Revenue GuidanceRevenue Estimate at Guidance
Q1 20263-$0.31-$0.19-$0.23
Q2 20263-$0.18-$0.06-$0.11
Q3 20263-$0.20-$0.08-$0.14
Q4 20263-$0.17-$0.01-$0.10
FY 202612-$0.86-$0.34-$0.59
Q1 20272-$0.20-$0.19-$0.20
Q2 20272-$0.18-$0.04-$0.11
Q3 20272-$0.20-$0.08-$0.14

Lifecore Biomedical Earnings History by Quarter

Report Date
0 Results
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/4/2026Q1 2027-$0.2975-$1.08 -$0.7825-$1.08$25.57M$25.32M
8/5/2026Q2 2026-$0.19-$0.19--$0.19$34.18M$34.17M
5/6/2026Q1 2026-$0.29-$0.43 -$0.14-$0.43$25.96M$23.19M
3/16/2026Transition period-$0.11-$0.16 -$0.05-$0.16$35.31M$35.75M
11/6/2025Q1 2026-$0.30-$0.29+$0.01-$0.29$26.68M$31.11M
8/7/2025Q4 2025-$0.09-$0.10 -$0.01-$0.06$35.36M$36.44M
4/3/2025Q3 2025-$0.14-$0.19 -$0.05-$0.47$33.23M$35.15M
1/2/2025Q2 2025-$0.27-$0.25+$0.02-$0.25-$32.56M

Lifecore Biomedical Earnings - Frequently Asked Questions

Lifecore Biomedical (NASDAQ:LFCR) last announced its quarterly earning data on Wednesday, November 4, 2026. Learn more on LFCR's earnings history.

In the previous quarter, Lifecore Biomedical (NASDAQ:LFCR) missed the analysts' consensus estimate of ($0.30) by $0.78 with a reported earnings per share (EPS) of ($1.08). Learn more on analysts' earnings estimate vs. LFCR's actual earnings.

Lifecore Biomedical's earnings report can be found in their filing with the SEC.
View SEC filing

Lifecore Biomedical (NASDAQ:LFCR) has a recorded annual revenue of $128.87 million.

Lifecore Biomedical's earnings are expected to grow from ($1.83) per share to ($1.08) per share in the next year.


Earnings data for NASDAQ:LFCR is sourced from Fiscal.ai, with the most recent quarter reported on 11/4/2026. New results are added as companies report their earnings.
From Our Partners